compound introduction
LHC-165 is a TLR7 agonist. LHC-165 has potential to used in study of solid tumors Form:Solid IC50& Target:TLR7
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
LHC-165
CAS number：1258595-14-0 molecular formula：C29H32F2N3O7P
overview
Specs
| Chinese alias | - | ||
| English alias | LHC165 | LHC-165 | RD02U4QLM1 | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid | SCHEMBL174281 | UNII-RD02U4QLM1 | Benzo(F)(1,7)naphthyridine-8-propanoic acid, 5-amino-2-(2 | ||
| CAS number | 1258595-14-0 | molecular formula | C29H32F2N3O7P |
| molecular weight | 603.55 g/mol | Exact mass | ≥98% |
| PSA | 165.000 Ų | logp | 3.600 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
